Clincosm LogoSign in Get a demo

Refractory Non-Hodgkin Lymphoma

Showing 26 - 44 of 44
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignant Solid Tumor, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +35 more
  • Birmingham, Alabama
  • +113 more
Jun 28, 2022

Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in Jinan (CAR-T cells)

Recruiting
  • Relapsed Non-Hodgkin Lymphoma
  • +2 more
  • CAR-T cells
  • Jinan, Shandong, China
    The Second People's Hospital of Shandong Province
Jun 14, 2022

Relapsed Non Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Cleveland (Loncastuximab tesirine, Venetoclax)

Recruiting
  • Relapsed Non Hodgkin Lymphoma
  • Refractory Non-Hodgkin Lymphoma
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cance
May 20, 2022

Refractory Non-Hodgkin Lymphoma, Burkitt Lymphoma, Mantle Cell Lymphoma Trial in San Francisco (Fludarabine, Cyclophosphamide,

Recruiting
  • Refractory Non-Hodgkin Lymphoma
  • +8 more
  • San Francisco, California
    University of California, San Francisco
May 2, 2022

CNS Lymphoma, Gastric Mantle Cell Lymphoma, Recurrent Mantle Cell Lymphoma Trial in Houston (Akt/ERK Inhibitor ONC201,

Terminated
Has Results
  • Central Nervous System Lymphoma
  • +6 more
  • Akt/ERK Inhibitor ONC201
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 30, 2022

AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Non-Hodgkin Lymphoma, HIV Infection Trial (Axicabtagene Ciloleucel,

Not yet recruiting
  • AIDS-Related Diffuse Large B-cell Lymphoma
  • +14 more
  • Axicabtagene Ciloleucel
  • +2 more
  • (no location specified)
Feb 15, 2022

Non Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma Trial in Boston (Anakinra, Axicabtagene

Recruiting
  • Non Hodgkin Lymphoma
  • +5 more
  • Boston, Massachusetts
  • +1 more
Oct 28, 2021

Hematopoietic Cell Transplantation Recipient, Recurrent DLBCL, Recurrent Grade 1 Follicular Lymphoma Trial in Columbus

Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • +11 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 29, 2021

Relapsed Non Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Suzhou (CD19/22 CART, Tislelizumab)

Unknown status
  • Relapsed Non Hodgkin Lymphoma
  • Refractory Non-Hodgkin Lymphoma
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jul 30, 2021

ASCT Bridging CART Cell Therapy in Relapsed/Refractory B-cell

Recruiting
  • Relapsed Non Hodgkin Lymphoma
  • Refractory Non-Hodgkin Lymphoma
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Jun 7, 2021

    B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Chronic

    Terminated
    • B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged
    • +16 more
    • Autologous CD19-CD8-CD28-CD3zeta-CAR-mbIL15-HER1t T Cells
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    May 28, 2021

    Relapsed Non Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Mexico City (Rituximab, Carboplatin, Cytarabine

    Completed
    • Relapsed Non Hodgkin Lymphoma
    • Refractory Non-Hodgkin Lymphoma
    • Mexico City, Azcapotzalco, Mexico
      Hospital Especialidades Centro Medico La Raza
    May 15, 2021

    Relapsed Non Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Seoul (Rituximab, Fludarabine, Cyclophosphamide)

    Unknown status
    • Relapsed Non Hodgkin Lymphoma
    • Refractory Non-Hodgkin Lymphoma
    • Seoul, Korea, Republic of
    • +2 more
    Jul 26, 2020

    Prolymphocytic Leukemia, Recurrent Adult Hodgkin Lymphoma, Recurrent Childhood Hodgkin Lymphoma Trial in Salt Lake City,

    Completed
    Has Results
    • Prolymphocytic Leukemia
    • +13 more
    • Autologous Hematopoietic Stem Cell Transplantation
    • +14 more
    • Salt Lake City, Utah
    • +4 more
    Jan 17, 2020

    Relapsed Non Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Maywood (Total body irradiation)

    Completed
    • Relapsed Non Hodgkin Lymphoma
    • Refractory Non-Hodgkin Lymphoma
    • Total body irradiation
    • Maywood, Illinois
      Patrick Stiff, MD
    Aug 19, 2019

    Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Shenzhen (CD19 CART)

    Unknown status
    • Relapsed Non-Hodgkin Lymphoma
    • Refractory Non-Hodgkin Lymphoma
    • CD19 CART
    • Shenzhen, China
      Shenzhen University General Hospital
    Jul 7, 2019

    B-Cell Prolymphocytic Leukemia, Hypodiploidy, Loss of Chromosome 17p Trial in Seattle, Milwaukee (procedure, drug, other,

    Completed
    Has Results
    • B-Cell Prolymphocytic Leukemia
    • +20 more
    • Allogeneic Bone Marrow Transplantation
    • +14 more
    • Seattle, Washington
    • +1 more
    May 31, 2019

    Relapsed Non Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, CAR - T CD19/CD20/CD22/CD30 Trial in Suzhou (CAR-T)

    Unknown status
    • Relapsed Non Hodgkin Lymphoma
    • +2 more
    • CAR-T
    • Suzhou, Jiangsu, China
      the First Affiliated Hospital of Soochow University
    Apr 14, 2019

    Diffuse Large B Cell Lymphoma, Relapsed Non Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Seoul (azacitidine plus

    Not yet recruiting
    • Diffuse Large B Cell Lymphoma
    • +2 more
    • azacitidine plus R-GDP
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Oct 23, 2018